Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Chiron's Menjugate approved in Ireland

Aug. 10, 2000

New peptides under development at Ludwig Institute

Aug. 9, 2000

New IL-5 inhibitors under development at Janssen

Aug. 8, 2000

New TNF inhibitors under development at Daiichi

Aug. 7, 2000

Peptide Therapeutics awarded SBIR grant for West Nile vaccine

Aug. 4, 2000

New human lymphocytic membrane proteins under study at Incyte

Aug. 3, 2000

Improved recombinant HBsAg for use in vaccines under study at Merck

Aug. 2, 2000

Rapamune regulatory application receives negative opinion from CPMP

Aug. 1, 2000

Cimetidine as treatment for viral warts in children and adults

Aug. 1, 2000

Novel classes of calcium-activated SK/IK/BK channel modulators designed at NeuroSearch

July 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...